| Helix Resources Limited (HLX) ORDINARY FULLY PAID |
Materials |
$5 |
Becoming a substantial holder
|
30 Aug 2024 10:33AM |
$0.005 |
$0.002 |
fallen by
66.67%
|
|
| Helix Resources Limited (HLX) ORDINARY FULLY PAID |
Materials |
$5 |
Intention to Make Takeover Bid
|
30 Aug 2024 10:33AM |
$0.005 |
$0.002 |
fallen by
66.67%
|
|
HLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of a proportional all-cash off-market takeover offer by Acta Investment Group Pty Ltd.
- Offer to acquire 25% of all ordinary shares of Helix that Acta and its associates do not currently hold or control.
- Acta and its associate Nuevo Royalty Limited currently hold a 9.42% stake in Helix.
- Offer price set at $0.005 per share, representing a 39% premium to Helix's 30-day VWAP.
- Bidder's Statement to be provided within 2 months, detailing how shareholders can accept the offer.
- Conditions and prescribed occurrences laid out in Annexure A.
- Helix not to proceed with any alternative proposals or offers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sayona Mining Limited (SYA) ORDINARY FULLY PAID |
Materials |
$185 |
Appendix 4G and Corporate Governance Statement
|
30 Aug 2024 10:33AM |
$0.027 |
$0.016 |
fallen by
39.62%
|
|
| Vectus Biosystems Limited (VBS) ORDINARY FULLY PAID |
Health Care |
$2 |
Agreement with C14 Consulting Group
|
30 Aug 2024 10:32AM |
$0.087 |
$0.040 |
fallen by
54.02%
|
|
VBS - Price-sensitive ASX Announcement
Full Release
Key Points
- Vectus Biosystems Limited (VBS) has appointed C14 Consulting Group, LLC in an exclusive role.
- C14 will lead and manage potential licensing, joint ventures, or both for Vectus’ portfolio of patented small therapeutic molecules.
- VB0004 along with A32 and A79 target reversal of disease in the heart, lung, kidney, and liver.
- VB0004 has successfully undergone Phase Ia and Phase Ib human trials with no adverse events.
- C14 Consulting Group, led by CEO Martina Molsbergen, is experienced in securing licensing agreements and joint ventures in the pharmaceutical industry.
- The agreement includes a management fee and an outcome-based success component aligning the interests of both parties.
- C14 will manage existing discussions and expand outreach to potential pharmaceutical partners.
- Dr. Ron Shnier, Vectus Non-Executive Chairman, expressed contentment in partnering with C14.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Allegra Medical Technologies Limited (AMT) ORDINARY FULLY PAID |
Health Care |
- |
Change of Director's Interest Notice - SM
|
30 Aug 2024 10:31AM |
$0.029 |
$0.029 |
fallen by
0%
|
|
| Sayona Mining Limited (SYA) ORDINARY FULLY PAID |
Materials |
$185 |
Annual Report to Shareholders
|
30 Aug 2024 10:29AM |
$0.027 |
$0.016 |
fallen by
39.62%
|
|
| Lark Distilling Co. Ltd (LRK) ORDINARY FULLY PAID |
Consumer Staple |
$79 |
Chair's EGM Address & CEO Presentation
|
30 Aug 2024 10:27AM |
$0.940 |
$0.745 |
fallen by
20.74%
|
|
| EBOS Group Limited (EBO) ORDINARY FULLY PAID |
Health Care |
$7,036 |
Application for quotation of securities - EBO
|
30 Aug 2024 10:27AM |
$32.320 |
$34.620 |
risen by
7.12%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$398 |
Full-Year Results Presentation
|
30 Aug 2024 10:25AM |
$0.178 |
$0.300 |
risen by
69.01%
|
|
| Sayona Mining Limited (SYA) ORDINARY FULLY PAID |
Materials |
$185 |
Appendix 4E
|
30 Aug 2024 10:24AM |
$0.027 |
$0.016 |
fallen by
39.62%
|
|
SYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased to $200,873,000 from $0.
- Loss from ordinary activities after tax attributable to members is $101,398,000, a significant increase from $11,048,000.
- No dividends were declared or paid for the year ended 30 June 2024.
- Net tangible assets per ordinary security decreased from $0.09 to $0.08.
- Interests in joint arrangements include the Moblan Lithium Project, Morella Lithium Joint Venture, and Vallée Lithium Project.
- No material changes to the Mineral Resources and Ore Reserves since the last announcement.
- The financial report was audited by Nexia Brisbane Audit Pty Ltd with an unqualified opinion.
- The Appendix 4E relates to the financial year from 1 July 2023 to 30 June 2024.
- The group’s interest in the Vallée Lithium Project increased to 25% as of December 14, 2023.
- All disclosure requirements pursuant to ASX Listing Rule 4.3A are contained within Sayona's Annual Report for the year ended 30 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| First Graphene Limited (FGR) ORDINARY FULLY PAID |
Materials |
$19 |
Preliminary Final Report
|
30 Aug 2024 10:24AM |
$0.052 |
$0.026 |
fallen by
50%
|
|
FGR - Price-sensitive ASX Announcement
Full Release
Key Points
- First Graphene Limited (FGR) is focused on developing and commercializing high-quality graphene products.
- The company has made significant progress in its research and development efforts.
- FGR is exploring various applications for its graphene products, including energy storage, structural materials, and coatings.
- The company has entered into several partnerships and collaborations to expand its market reach.
- FGR has reported positive financial performance with increased revenue and reduced operational costs.
- The company is committed to sustainability and environmentally friendly practices in its operations.
- FGR is actively pursuing new opportunities in the global market for graphene products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genetic Technologies Limited (GTG) ORDINARY FULLY PAID |
Health Care |
$52 |
FY24 results announcement and operations update
|
30 Aug 2024 10:22AM |
$0.039 |
$0.039 |
fallen by
0%
|
|
GTG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues of $7.665 million for FY2024, down from $8.686 million in FY2023
- Loss after tax increased by 2.3% to $12.017 million
- Gross profit reduced by 10.3% with a slight improvement in gross margin
- R&D expenses reduced by 41.2% as geneType technology neared commercialization
- Company secured $800,000 in short-term loan funding for restructuring
- Transition to a capital light operating model to reduce costs
- Entitlement Offer to raise between $2 million and $3.85 million
- Core focus on EasyDNA and geneType brands
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Opyl Limited (OPL) ORDINARY FULLY PAID |
Information Technology |
$4 |
Change to Webinar Date
|
30 Aug 2024 10:20AM |
$0.016 |
$0.019 |
risen by
18.75%
|
|
| MoneyMe Limited (MME) ORDINARY FULLY PAID |
Financials |
$112 |
FY24 Sustainability Report
|
30 Aug 2024 10:20AM |
$0.105 |
$0.140 |
risen by
33.33%
|
|
| Althea Group Holdings Limited (AGH) ORDINARY FULLY PAID |
Health Care |
$22 |
Appendix 4G and Corporate Governance Statement
|
30 Aug 2024 10:17AM |
$0.020 |
$0.027 |
risen by
35%
|
|
| International Equities Corporation Limited (IEQ) ORDINARY FULLY PAID |
Real Estate |
$5 |
Preliminary Final Report
|
30 Aug 2024 10:15AM |
$0.040 |
$0.040 |
fallen by
0%
|
|
IEQ - Price-sensitive ASX Announcement
Full Release
Key Points
- International Equities Corporation Limited (IEQ) submitted its preliminary final report for the year ended 30 June 2024.
- The revenue from continuing operations was $2,599,000, a slight decrease from the previous year's $2,698,000.
- The revenue from discontinued operations was $2,941,000, a significant decrease from the previous year's $5,968,000.
- The net profit attributable to members of the parent entity was $467,000, compared to a loss of $650,000 in the previous year.
- The company’s net tangible asset backing per ordinary security increased to 4.93 cents from 4.56 cents.
- No dividends were declared or paid during the year.
- The consolidated entity's total liabilities decreased from $29,362,000 as of 30 June 2023 to $7,847,000 as of 30 June 2024.
- Net assets increased from $5,864,000 as of 30 June 2023 to $6,331,000 as of 30 June 2024.
- The company's activities included property development, tourism, and leasing, with a particular focus on tourism and leasing of residential properties.
- The company sold Seasons of Perth Hotel to pay down loans, which was settled on 4 October 2023.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansarada Group Limited (AND) ORDINARY FULLY PAID |
Information Technology |
- |
Change of Director's Interest Notice x5
|
30 Aug 2024 10:14AM |
$2.490 |
$2.490 |
fallen by
0%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$398 |
Full-Year Results Release
|
30 Aug 2024 10:13AM |
$0.178 |
$0.300 |
risen by
69.01%
|
|
| Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$107 |
Suspension from Quotation
|
30 Aug 2024 10:11AM |
$0.005 |
$0.052 |
risen by
940%
|
|
ESR - Price-sensitive ASX Announcement
Full Release
Key Points
- Estrella Resources Limited requests voluntary suspension
- Suspension under ASX Listing Rule 17.2
- Pending announcement regarding capital raising
- Suspension anticipated to end by 3 September 2024
- Board of Directors authorized the announcement
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$398 |
Appendix 4G and Corporate Governance Statement
|
30 Aug 2024 10:11AM |
$0.178 |
$0.300 |
risen by
69.01%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$398 |
Annual Report to Shareholders 2024
|
30 Aug 2024 10:10AM |
$0.178 |
$0.300 |
risen by
69.01%
|
|
| Maggie Beer Holdings Ltd (MBH) ORDINARY FULLY PAID |
Consumer Staple |
$26 |
FY24 Results Presentation
|
30 Aug 2024 10:10AM |
$0.067 |
$0.072 |
risen by
7.46%
|
|
MBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 0.8% compared to FY23.
- Retail and online revenue both increased by 0.7% and 0.8% respectively.
- Gross margin decreased by 1.1 percentage points due to delayed price recovery, shifting channel and product mix, and inventory write-offs.
- Trading EBITDA decreased significantly by 91.0% compared to FY23.
- Statutory EBITDA showed a notable loss mainly due to impairments of Goodwill and other assets.
- Maggie Beer Products reported a 6.3% increase in net sales, but gross margin fell by 2.0 percentage points.
- Hamper and Gifts Australia (HGA) saw a marginal net sales increase of 0.7%, with a gross margin decline of 2.0 percentage points.
- Paris Creek Farms (PCF) experienced a 9.5% drop in net sales.
- Significant focus on e-commerce platform enhancement and strategic brand partnerships.
- Plan to focus on profit-driving sectors and streamline operations for FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maggie Beer Holdings Ltd (MBH) ORDINARY FULLY PAID |
Consumer Staple |
$26 |
FY24 Results Announcement
|
30 Aug 2024 10:09AM |
$0.067 |
$0.072 |
risen by
7.46%
|
|
MBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net Sales from continuing operations $89.4 million; up 0.8% on the prior year.
- Maggie Beer Products (MBP) net sales up 6.3% driven by category expansion in retail and positive momentum in revenue growth from online sales.
- Hampers & Gifts Australia (HGA) net sales up 0.7% FY24, with strong Christmas execution delivering +8% sales in Q2.
- Paris Creek Farms (PCF) net sales down 9.5%; primarily driven by lower milk supply.
- Gross Margin was down 1.1 percentage points to 49.2%.
- Trading EBITDA $0.3 million, reflecting earnings loss in PCF and delayed input cost recovery.
- MBH has no debt with a net cash position of $4.7 million at 30 June 2024.
- Reported Net Loss After Tax ($24.8 million), including non-cash impairments and provisions.
- Management changes include the appointment of Penny Diamantakiou as Chief Operating Officer and Chief Financial Officer.
- FY25 priorities focus on returning to profitability, enhancing e-commerce, and leveraging iconic Australian brand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Althea Group Holdings Limited (AGH) ORDINARY FULLY PAID |
Health Care |
$22 |
AGH FY24 Annual Report Commentary
|
30 Aug 2024 10:08AM |
$0.020 |
$0.027 |
risen by
35%
|
|
AGH - Price-sensitive ASX Announcement
Full Release
Key Points
- AGH reported a 21% revenue increase, reaching $30.36 million in FY24.
- Strategic cost-saving measures are projected to save $2.5 million annually from May 2024.
- Althea saw a 46% revenue increase in the UK.
- Peak Processing Solutions in Canada is expected to have substantial growth in FY25.
- AGH plans to enter the US market via Peak USA Inc. in September 2024.
- A non-cash impairment of $17.74 million was recorded for Peak Canada.
- Management identified an additional $1.5 million in annual cost savings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$398 |
Appendix 4E
|
30 Aug 2024 10:08AM |
$0.178 |
$0.300 |
risen by
69.01%
|
|
TTT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 71.5% to $7,697,370
- Loss from ordinary activities after tax decreased by 24.3% to $11,892,164
- Total comprehensive loss attributable to owners decreased by 23.4% to $11,994,468
- No dividends were paid, recommended, or declared during the current financial period
- Net tangible assets per ordinary security improved from -0.0030 cents to 0.0010 cents
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
